Maximum bite force in patients with spinal muscular atrophy during the first year of nusinersen therapy - A pilot study
{{output}}
Objectives: Spinal muscular atrophy is a monogenic disease characterized by progressive spinal and bulbar muscle weakness and atrophy. It is caused by the degeneration of alpha-motoneurons. The recent approval of the antisense ol... ...
